Organon (NYSE: OGN) reported Q4 EPS of $0.63, $0.13 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.54 billion.

GUIDANCE:

Organon sees FY2026 revenue of $6.2 billion, versus the consensus of $6.111 billion.

For earnings history and earnings-related data on Organon (OGN) click here.